Universal-Beteiligungs- und Servicegesellschaft
NAGE icon

Universal-Beteiligungs- und Servicegesellschaft’s Niagen Bioscience NAGE Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,084
Closed -$147K – 2153
2025
Q4 		$147K Buy
+23,084
New +$161K ﹤0.01% 2007

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NAGE Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 23,084 shares — an estimated $147K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NAGE in Q4 2025 and held it in 1 quarter. The position peaked at $147K in Q4 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 23,084 Niagen Bioscience shares in Q1 2026, an estimated $147K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Niagen Bioscience in Q4 2025 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Niagen Bioscience position peaked at $147K in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.